Monthly Archives: October 2018

BriaCell Initiates Dosing in Phase I/IIa Combination Study with KEYTRUDA® or YERVOY®
October 9, 2018

· Patient dosing is underway in a combination study of Bria-IMT™ with KEYTRUDA® (by Merck ...